Whitehawk Therapeutics Inc. Company Profile
NASDAQ: WHWKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Whitehawk Therapeutics at a glance
Whitehawk Therapeutics Inc. (NASDAQ: WHWK) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Morristown, NJ. Whitehawk Therapeutics is led by Dr. David J. Lennon Ph.D. and employs about 32 people. At a market capitalization of $197.8 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001422142, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Whitehawk Therapeutics do?
Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.
Business description based on the company's public filings.
Company information
- Legal name
- Whitehawk Therapeutics Inc.
- Ticker
- NASDAQ: WHWK
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Dr. David J. Lennon Ph.D.
- Employees
- 32
- Headquarters
- 2 Headquarters Plaza, Morristown, NJ, United States
- Phone
- 551 321 2234
- Website
- ir.whitehawktx.com
- Market cap
- $197.82M
- SEC CIK
- 0001422142
Companies similar to Whitehawk Therapeutics
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| CUECue Biopharma Inc. | 27.66 | +23.87% | $200.93M | vs WHWK |
| ELDNEledon Pharmaceuticals Inc. | 2.48 | +2.48% | $201.53M | vs WHWK |
| NGENNervGen Pharma Corp. | 1.73 | -1.14% | $186.01M | vs WHWK |
| ADAGAdagene Inc. ADR | 2.76 | -0.72% | $185.32M | vs WHWK |
| LYELLyell Immunopharma Inc. | 8.71 | -0.91% | $213.44M | vs WHWK |
| RNACCartesian Therapeutics Inc. | 7.06 | +3.45% | $213.45M | vs WHWK |
| ORMPOramed Pharmaceuticals Inc. | 4.33 | +3.10% | $180.12M | vs WHWK |
| DERMJourney Medical Corporation | 6.31 | +6.05% | $178.10M | vs WHWK |